Literature DB >> 16224610

Comparing the prevalence rates of social phobia in a community according to ICD-10 and DSM-III-R.

Fábio Lopes Rocha1, Cláudia Maria Resende Vorcaro, Elizabeth Uchoa, Maria Fernanda Lima-Costa.   

Abstract

OBJECTIVE: This population-based study aimed to compare the prevalence rates of social phobia using DSM-III-R and CID-10, based on the Composite International Diagnostic Interview (CIDI), in a Brazilian community.
METHODS: This survey was carried out in a representative sample of 1,041 residents from Bambuí, Minas Gerais, Brazil (attrition rate = 14.7%). The Brazilian version of the CIDI was used. One-month, one-year and lifetime social phobia prevalence rates were estimated, employing the DSM-III-R and ICD-10 classifications, using the CIDI computer program.
RESULTS: One-month, one-year, and life prevalence rates of social phobia, based on the DSM-III-R (7.9, 9.0 and 11.7% respectively) were higher than those based on the ICD-10 (4.7, 5.2 and 6.7% respectively; p < 0.01 for all).
CONCLUSION: Our results reinforce the hypothesis that the prevalence of social phobia is higher when based on the DSM-III-R compared to the ICD-10 classification.

Entities:  

Mesh:

Year:  2005        PMID: 16224610     DOI: 10.1590/s1516-44462005000300011

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  3 in total

Review 1.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

2.  Cognitive behavioral therapy in social phobia: Indian context.

Authors:  Samput Mallick
Journal:  Ind Psychiatry J       Date:  2010-01

3.  The Prevalence and Sociodemographic Correlates of Social Anxiety Disorder: A Focused National Survey.

Authors:  Aamal Ambusaidi; Salim Al-Huseini; Hiba Alshaqsi; Manal AlGhafri; Moon-Fai Chan; Nasser Al-Sibani; Samir Al-Adawi; M Walid Qoronfleh
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.